Sino Biopharmaceutical (SBMFF) News Today $0.68 0.00 (0.00%) As of 07/3/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesSEC FilingsShort InterestBuy This Stock SBMFF Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Sino Biopharmaceutical (OTCMKTS:SBMFF) Sees Large Volume Increase - Time to Buy?July 2 at 2:57 PM | marketbeat.comSino Biopharmaceutical Ltd (1177) - Investing.com UKJuly 1 at 3:32 AM | uk.investing.comSino Biopharmaceutical (OTCMKTS:SBMFF) Trading 8.7% Higher - Still a Buy?June 23, 2025 | marketbeat.comSino Biopharmaceutical (OTCMKTS:SBMFF) Sees Large Decline in Short InterestJune 18, 2025 | marketbeat.comSino Biopharmaceutical (OTCMKTS:SBMFF) Trading Down 4.4% - Should You Sell?June 17, 2025 | marketbeat.comSino Biopharmaceutical (OTCMKTS:SBMFF) Sets New 12-Month High - Time to Buy?June 10, 2025 | marketbeat.comSino Biopharmaceutical Secures Shareholder Approval for Key Resolutions at AGMJune 10, 2025 | tipranks.comSino Biopharmaceutical (OTCMKTS:SBMFF) Sets New 12-Month High - Still a Buy?June 4, 2025 | marketbeat.comSino Biopharmaceutical’s Phase III Study Shows Promising Results for NSCLC TreatmentJune 3, 2025 | tipranks.comSBMFF Sino Biopharmaceutical LimitedMay 29, 2025 | seekingalpha.comSino Biopharmaceutical (OTCMKTS:SBMFF) Sets New 52-Week High - Should You Buy?May 29, 2025 | marketbeat.comSino Biopharmaceutical’s TQB2868 Shows Promise in Pancreatic Cancer TreatmentMay 29, 2025 | tipranks.comSino Biopharmaceutical Unveils Promising Phase I Data for TQB2102 at ASCO 2025May 27, 2025 | tipranks.comSino Biopharmaceutical (OTCMKTS:SBMFF) Trading 5.3% Higher - Time to Buy?May 14, 2025 | marketbeat.comGlobal First-in-Class AT2R Antagonist TRD205 Advances to Phase II: First Patient Dosed in Chronic Post-Surgical Neuropathic Pain TrialMay 6, 2025 | msn.comU.S. FDA Approves China-Produced Cancer DrugApril 28, 2025 | forbes.comSino Biopharmaceutical’s Penpulimab Injection Gains US FDA ApprovalApril 25, 2025 | tipranks.comSino Biopharmaceutical (OTCMKTS:SBMFF) Hits New 52-Week High - Here's What HappenedApril 24, 2025 | marketbeat.comSino Biopharmaceutical to Showcase 45 Research Results at 2025 ASCO MeetingApril 24, 2025 | tipranks.comSino Biopharmaceutical Limited (OTCMKTS:SBMFF) Short Interest Down 79.5% in MarchApril 16, 2025 | marketbeat.comSino Biopharmaceutical’s TQB3019 Approved for Clinical TrialsApril 9, 2025 | tipranks.comSino Biopharmaceutical Receives Approval for Clinical Trial of New Cancer DrugApril 3, 2025 | tipranks.comSino Biopharmaceutical’s TQB6411 Clinical Trial Application AcceptedApril 3, 2025 | tipranks.comSino Biopharmaceutical (OTCMKTS:SBMFF) Trading 4.9% Higher - Still a Buy?March 25, 2025 | marketbeat.comSino Biopharmaceutical Reports Positive Phase III Results for Breast Cancer TreatmentMarch 24, 2025 | tipranks.comAsian Market Insights: Sino Biopharmaceutical And 2 Other Prominent Penny StocksMarch 20, 2025 | finance.yahoo.comSino Biopharmaceutical Partners with Sciwind for Innovative RSV TreatmentFebruary 27, 2025 | tipranks.comDiscovering Value: 3 Penny Stocks With At Least US$700M Market CapFebruary 19, 2025 | finance.yahoo.comSino Biopharmaceutical Gains Approval for Innovative Tulobuterol PatchFebruary 6, 2025 | tipranks.comSino Biopharmaceutical (OTCMKTS:SBMFF) Trading Down 12.3% - Here's What HappenedJanuary 30, 2025 | marketbeat.comSino Biopharmaceutical Limited (OTCMKTS:SBMFF) Short Interest Up 20.6% in DecemberDecember 29, 2024 | marketbeat.com3 Promising Penny Stocks With Market Caps Under US$11BDecember 23, 2024 | finance.yahoo.comSino Biopharmaceutical’s Promising Liver Cancer Treatment AdvancementNovember 21, 2024 | markets.businessinsider.comSino Biopharm Invests in LaNova for Cancer InnovationsNovember 20, 2024 | markets.businessinsider.comSino Biopharmaceutical’s Strategic Investment in BiotechNovember 17, 2024 | msn.comSino Biopharmaceutical Gains FDA Approval for New Cancer DrugNovember 15, 2024 | markets.businessinsider.comSino Biopharm’s Garsorasib Gains Approval in ChinaNovember 11, 2024 | markets.businessinsider.comSino Biopharmaceutical Sees Strong Q3 Financial GrowthNovember 1, 2024 | markets.businessinsider.comSino Biopharmaceutical to Boost Market Share through Strategic AcquisitionsOctober 31, 2024 | markets.businessinsider.comSino Biopharmaceutical (SBMFF) Receives a Buy from JefferiesOctober 27, 2024 | markets.businessinsider.comSino Biopharmaceutical Limited (OTCMKTS:SBMFF) Short Interest Up 755.8% in OctoberOctober 25, 2024 | marketbeat.comSino Biopharmaceutical And 2 Other Promising Penny Stocks To WatchOctober 22, 2024 | finance.yahoo.comSino Biopharmaceutical Limited (OTCMKTS:SBMFF) Short Interest Up 418.8% in SeptemberOctober 10, 2024 | marketbeat.comSino Biopharmaceutical Limited (OTCMKTS:SBMFF) Short Interest Down 99.5% in AugustSeptember 12, 2024 | marketbeat.comSino Biological and BioGeometry Deepen Strategic Cooperation to Empower Protein R&D with Generative AISeptember 12, 2024 | msn.comShort Interest in Sino Biopharmaceutical Limited (OTCMKTS:SBMFF) Drops By 91.5%August 27, 2024 | marketbeat.comSino Biopharmaceutical Limited (SBMFF)August 23, 2024 | finance.yahoo.comSino Biopharmaceutical Limited (OTCMKTS:SBMFF) Sees Significant Decline in Short InterestAugust 13, 2024 | marketbeat.comSino Biopharmaceutical Limited (OTCMKTS:SBMFF) Short Interest UpdateJuly 11, 2024 | marketbeat.comSino Biopharmaceutical Limited (OTCMKTS:SBMFF) Short Interest Down 100.0% in JuneJune 27, 2024 | marketbeat.com Get Sino Biopharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for SBMFF and its competitors with MarketBeat's FREE daily newsletter. Email Address SBMFF Media Mentions By Week SBMFF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SBMFF News Sentiment▼0.380.55▲Average Medical News Sentiment SBMFF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SBMFF Articles This Week▼20▲SBMFF Articles Average Week Get Sino Biopharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for SBMFF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALNY News Today ARGX News Today BNTX News Today RPRX News Today INSM News Today BIIB News Today ILMN News Today GNMSF News Today INCY News Today GMAB News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SBMFF) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredRevealed: NEW A.I. revolution (nobody is talking about)Nvidia's CEO says this is: "The next wave of A.I." We're at the cusp of a new "A.I. Upgrade" that is set to...Behind the Markets | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sino Biopharmaceutical Please log in to your account or sign up in order to add this asset to your watchlist. Share Sino Biopharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
